skip to Main Content

New study from Intuitive Biosciences uses CSA assays to monitor candidate vaccine efficacy in nonhuman primate model for SARS-CoV-2.

"A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques." Gary Baisa, David Rancour, Keith Mansfield, Monika Burns, Lori Martin, Daise Cunha, Jessica Fischer,  Frauke Muecksch, Theodora Hatziioannou, Paul D. Bieniasz, Fritz Schomburg, Kimberly Luke* *corresponding author: kluke@intuitivebio.com Vaccines that generate robust and long-lived protective immunity against SARS-CoV-2 infection are urgently required. We assessed the potential of vaccine candidates based…

Setting up in-house serology testing

Many research institutions and CROs outsource their serology screening. This can often be a convenient way to get the results needed without having staff and laboratory space committed to that purpose. However, COVID-19 highlighted the need for local services when…

Search